Calidi Biotherapeutics Files 8-K with Financials
Ticker: CLDWW · Form: 8-K · Filed: Apr 10, 2025 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, regulation-fd
Related Tickers: CLDI
TL;DR
Calidi Biotherapeutics (CLDI) filed an 8-K on 4/10 with financial updates from 4/8.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on April 10, 2025, reporting an event on April 8, 2025. The filing indicates a Regulation FD Disclosure and includes Financial Statements and Exhibits. The company, formerly known as First Light Acquisition Group, Inc. until April 6, 2021, is based in San Diego, California.
Why It Matters
This 8-K filing provides updated information and financial disclosures for Calidi Biotherapeutics, Inc., which is crucial for investors to assess the company's current status and performance.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial statements and exhibits, not indicating any immediate material adverse events.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- First Light Acquisition Group, Inc. (company) — Former company name
- April 8, 2025 (date) — Earliest event reported
- April 10, 2025 (date) — Filing date
- San Diego, CA (location) — Company address
FAQ
What specific event triggered the Regulation FD Disclosure?
The filing does not specify the exact event that triggered the Regulation FD Disclosure, only that it was reported on April 8, 2025.
What type of financial statements are included in this filing?
The filing indicates that Financial Statements and Exhibits are included, but the specific details of these statements are not provided in the header information.
When did Calidi Biotherapeutics, Inc. change its name from First Light Acquisition Group, Inc.?
The name change from First Light Acquisition Group, Inc. to Calidi Biotherapeutics, Inc. occurred on April 6, 2021.
What is Calidi Biotherapeutics, Inc.'s primary business sector?
Calidi Biotherapeutics, Inc. is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code 2836.
Where is Calidi Biotherapeutics, Inc. headquartered?
Calidi Biotherapeutics, Inc. is headquartered at 4475 Executive Drive, Suite 200, San Diego, CA 92121.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 10, 2025 regarding Calidi Biotherapeutics, Inc. (CLDWW).